Browsing: March 2021

The ideal oxygenation goal in patients with acute respiratory failure in the ICU remains unclear. The HOT ICU trial seeks to provide insight.
For this month’s addition to the Program Director Interview Series, we chatted with Dr. Todd Berger to learn about the Dell Medical School at The University of Texas at Austin Emergency Medicine Resid
Originally designed for use in rheumatoid arthritis, tocilizumab is being considered as a potential therapeutic agent to treat COVID-19.
While much is still left to be known about COVID-19, research has supported the theory that an excessive host inflammatory response is responsible for much of the morbidity and mortality seen by the d
Does treatment with vitamin C, thiamine, and hydrocortisone lead to an increase in the number of days alive and free of mechanical ventilation and vasopressor use? The latest EMRA Critical Care Alert
A recent study investigated COVID-19's impact on hospital visits. Patient volume plummeted - disproportionately affecting populations that already struggle with systemic inequities in healthcare.
The latest EMRA Critical Care Alert examines a study that questions whether ultra-short-acting beta-blockers, such as esmolol and landiolol, reduced 28-day mortality in septic patients with persistent